2021
DOI: 10.3892/or.2021.7927
|View full text |Cite
|
Sign up to set email alerts
|

Effects and mechanisms of Eps8 on the biological behaviour of malignant tumours (Review)

Abstract: Epidermal growth factor receptor pathway substrate 8 (Eps8) was initially identified as the substrate for the kinase activity of EGFR, improving the responsiveness of EGF, which is involved in cell mitosis, differentiation and other physiological functions. Numerous studies over the last decade have demonstrated that Eps8 is overexpressed in most ubiquitous malignant tumours and subsequently binds with its receptor to activate multiple signalling pathways. Eps8 not only participates in the regulation of malign… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 118 publications
(220 reference statements)
0
4
0
Order By: Relevance
“…Proteins of the epidermal growth factor substrate 8 (EPS8) family can regulate actin dynamics directly through capping or bundling, or indirectly through enhancement of Rac GTPase function (Hertzog et al, 2010; Luo et al, 2021). EPS8 is primarily localized to the tips of tall stereocilia, where it is thought to act mainly as an actin bundler.…”
Section: Microvillar Actin Cytoskeletonmentioning
confidence: 99%
“…Proteins of the epidermal growth factor substrate 8 (EPS8) family can regulate actin dynamics directly through capping or bundling, or indirectly through enhancement of Rac GTPase function (Hertzog et al, 2010; Luo et al, 2021). EPS8 is primarily localized to the tips of tall stereocilia, where it is thought to act mainly as an actin bundler.…”
Section: Microvillar Actin Cytoskeletonmentioning
confidence: 99%
“… 33 Reduced expression in tumor tissue of CTNNA1 has been suggested to be a marker for early-stage ovarian epithelial cancers with poor prognosis, 34 while decreased protein expression in different ovarian cancer cell lines have been shown to either increase or decrease sensitivity to different chemotherapies. 35 A recent review 36 of the role of EPS8, including the EPS8L2 homolog, reports overexpression (as seen here) in a large variety of cancers, including ovarian cancer with involvement in tumorigenesis, tumor proliferation, migration, metastasis as well as drug resistance and poor prognosis. Although several candidate biomarkers were found with strong statistical support comparing cases and controls in the screening scenario, we found no strong univariate candidates separating the benign tumors from malignant.…”
Section: Discussionmentioning
confidence: 63%
“…Multiple genes whose products act as cytoskeleton regulatory molecules were also upregulated, such as RHOF , WASL , CAP1 , MYL12B , LMTK3 , WDR , RHOD , SEPT2 , and WASF2 ( Figure 2 ). Moreover, the gene EPS8 , which codes for a receptor adaptor protein ( 92 ), and the EZR gene ( Figure 2 ) were upregulated. The AZR gene codes for the ezrin, a protein that belongs to the ERM (Ezrin–Radixin–Moesin) family and functions as a cross-linker between the actin cytoskeleton and the plasma membrane.…”
Section: Resultsmentioning
confidence: 99%